Stock Analysis on Net
Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

株価純利益率 (P/E) 
2005年以降

Microsoft Excel

計算

Regeneron Pharmaceuticals Inc.、 P/E、長期トレンド計算

Microsoft Excel
P/E = 株価1, 2, 3 ÷ 1株当たり利益1 (EPS) EPS1 = 当期純利益(損失)1
(数千で)		 ÷ 発行済普通株式数2
2024/02/05 25.99 = 936.33 ÷ 36.02 36.02 = 3,953,600 ÷ 109,761,896
2023/02/06 19.68 = 780.86 ÷ 39.68 39.68 = 4,338,400 ÷ 109,325,532
2022/02/07 8.37 = 622.36 ÷ 74.40 74.40 = 8,075,300 ÷ 108,539,282
2021/02/08 15.09 = 494.90 ÷ 32.79 32.79 = 3,513,200 ÷ 107,131,899
2020/02/07 19.86 = 381.87 ÷ 19.23 19.23 = 2,115,800 ÷ 110,019,809
2019/02/07 18.17 = 406.46 ÷ 22.37 22.37 = 2,444,400 ÷ 109,277,189
2018/02/08 28.99 = 322.62 ÷ 11.13 11.13 = 1,198,511 ÷ 107,696,798
2017/02/09 42.64 = 360.00 ÷ 8.44 8.44 = 895,522 ÷ 106,080,755
2016/02/11 60.50 = 367.24 ÷ 6.07 6.07 = 636,056 ÷ 104,788,145
2015/02/12 118.44 = 401.74 ÷ 3.39 3.39 = 348,074 ÷ 102,616,962
2014/02/13 77.00 = 326.98 ÷ 4.25 4.25 = 424,362 ÷ 99,928,368
2013/02/15 21.42 = 164.93 ÷ 7.70 7.70 = 750,269 ÷ 97,450,601
2012/02/21 — = 99.26 ÷ -2.36 -2.36 = -221,760 ÷ 93,888,977
2011/02/17 — = 37.67 ÷ -1.16 -1.16 = -104,468 ÷ 89,959,044
2010/02/18 — = 26.66 ÷ -0.83 -0.83 = -67,830 ÷ 81,653,378
2009/02/26 — = 15.40 ÷ -1.03 -1.03 = -82,710 ÷ 79,976,762
2008/02/27 — = 18.90 ÷ -1.34 -1.34 = -105,600 ÷ 78,984,745
2007/03/12 — = 19.04 ÷ -1.56 -1.56 = -102,337 ÷ 65,630,744
2006/02/28 — = 16.37 ÷ -1.68 -1.68 = -95,446 ÷ 56,858,721

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).

1 米ドル

2 分割と株式配当の調整済みデータ。

3 Regeneron Pharmaceuticals Inc.アニュアルレポート提出日時点の終値

競合他社との比較

Regeneron Pharmaceuticals Inc.、 P/E、長期トレンド、競合他社との比較

Microsoft Excel
Regeneron Pharmaceuticals Inc. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Moderna Inc. Pfizer Inc. Thermo Fisher Scientific Inc.
2024/02/05 25.99 63.84 23.14 12.27 39.09 135.24 16.17 10.73 893.99 — 73.42 35.65
2023/02/06 19.68 22.62 19.56 23.97 25.65 50.08 22.68 22.97 19.21 6.43 7.58 30.55
2022/02/07 8.37 22.07 21.05 20.92 29.94 40.66 12.36 20.93 14.78 5.00 11.76 27.35
2021/02/08 15.09 40.17 18.82 — 44.49 31.95 641.48 28.92 26.72 — 19.62 27.89
2020/02/07 19.86 17.82 17.07 41.99 38.34 16.19 16.45 25.99 20.60 — 11.63 33.36
2019/02/07 18.17 20.60 14.01 16.81 29.77 39.13 15.26 23.74 33.46 — 21.58 35.19
2018/02/08 28.99 35.47 64.06 103.55 27.25 — 22.75 268.10 61.63 — 9.99 37.66
2017/02/09 42.64 16.54 16.03 20.56 23.02 32.39 6.83 20.08 46.14 — 28.10 30.45
2016/02/11 60.50 17.01 15.95 64.22 17.85 33.35 6.75 18.80 31.64 — 26.37 26.19
2015/02/12 118.44 55.08 22.96 49.80 23.69 33.06 12.85 17.15 13.94 — 23.03 27.26
2014/02/13 77.00 19.64 18.69 35.01 19.74 13.88 42.00 18.72 37.83 — 9.32 38.43
2013/02/15 21.42 11.51 15.68 30.56 17.73 14.99 25.20 19.64 20.94 — 13.51 22.54
2012/02/21 — — 14.61 15.07 16.92 10.42 12.20 18.48 18.63 — 15.99 15.58
2011/02/17 — — 10.53 13.99 18.29 7.86 10.68 12.23 116.63 — 18.63 20.87
2010/02/18 — — 12.10 4.03 20.93 9.18 16.29 14.22 9.00 — 16.41 23.49
2009/02/26 — — 12.06 7.68 12.56 — 20.29 11.67 6.53 — 10.25 15.25
2008/02/27 — — 15.64 20.60 17.35 19.26 25.19 17.07 29.88 — 18.51 30.76
2007/03/12 — — 25.43 34.64 19.65 22.40 — 17.02 21.57 — 9.18 113.28
2006/02/28 — — 23.70 14.96 21.38 31.90 34.15 16.95 16.62 — 23.92 25.36

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).

産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス

Regeneron Pharmaceuticals Inc.、 P/E、長期トレンド、産業部門との比較: 製薬、バイオテクノロジー、ライフサイエンス

Microsoft Excel
Regeneron Pharmaceuticals Inc. 製薬、バイオテクノロジー、ライフサイエンス
2024/02/05 25.99 35.36
2023/02/06 19.68 19.24
2022/02/07 8.37 17.76
2021/02/08 15.09 37.29
2020/02/07 19.86 20.82
2019/02/07 18.17 23.13
2018/02/08 28.99 34.49
2017/02/09 42.64 20.28
2016/02/11 60.50 18.89
2015/02/12 118.44 20.74
2014/02/13 77.00 19.10
2013/02/15 21.42 17.34
2012/02/21 — 16.25
2011/02/17 — 15.61
2010/02/18 — 11.39
2009/02/26 — 11.95
2008/02/27 — 19.74
2007/03/12 — 17.28
2006/02/28 — 20.69

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).

業界との比較: 医療

Regeneron Pharmaceuticals Inc.、 P/E、長期トレンド、業界との比較: 医療

Microsoft Excel
Regeneron Pharmaceuticals Inc. 医療
2024/02/05 25.99 30.09
2023/02/06 19.68 314,676.00
2022/02/07 8.37 19.87
2021/02/08 15.09 29.50
2020/02/07 19.86 21.10
2019/02/07 18.17 25.51
2018/02/08 28.99 29.68
2017/02/09 42.64 21.38
2016/02/11 60.50 19.10
2015/02/12 118.44 20.89
2014/02/13 77.00 18.14
2013/02/15 21.42 15.43
2012/02/21 — 15.48
2011/02/17 — 14.45
2010/02/18 — 11.43
2009/02/26 — 12.78
2008/02/27 — 18.99
2007/03/12 — 18.38
2006/02/28 — 21.11

レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31), 10-K (報告日: 2011-12-31), 10-K (報告日: 2010-12-31), 10-K (報告日: 2009-12-31), 10-K (報告日: 2008-12-31), 10-K (報告日: 2007-12-31), 10-K (報告日: 2006-12-31), 10-K (報告日: 2005-12-31).